Pharmacological activities of Chelidonium majus L. (papaveraceae)

Pharmacological Research

Volumn 33, Issue 2, 1996, Pages 127-134

  Colombo, Maria Laura ^a   Bosisio, Enrica ^a  

^a NONE

Author keywords

Chelidonium majus L.; Isoquinoline alkaloids; Papaveraceae; Ukrain

Indexed keywords

BENZOPHENANTHRIDINE DERIVATIVE; BERBERINE; CHELERYTHRINE; CHELIDONINE; COPTISINE; FLAVONOID; ISOQUINOLINE ALKALOID; PLANT EXTRACT; PROTOBERBERINE; PROTOPINE; RNA DIRECTED DNA POLYMERASE; SANGUINARINE; UKRAIN; VASOPRESSIN V1 RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CHINESE MEDICINE; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG STRUCTURE; ENZYME INHIBITION; HERBAL MEDICINE; HUMAN; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL;

EID: 0030087560     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0019     Document Type: Article

References (63)

1. 1. Tutin TG. Flora Europea Vol. I, 1964; 247-51
2. 2. Paris RR, Moyse H. Précis de matière médicale. Vol. II, 1967; 207-8.
3. 3. Deutschmann F, Hommann B, Sprecher E, Stahl E. Pharmazeutische Biologie Drogenalyse I: Morphologie und Anatomie. 1979; 149-51.
4. 4. Langhammer L. Bildatlas zur mikroskopischen Analytik pflanzlicher Arzneidrogen. 1986; 26-7.
5. 5. Fulde G, Wichtl M. Analytik von Schöllkraut. Deutsche Apotheker Zeitung 1994; 135: 1031-5.
6. 6. Hegnauer R. Chemotaxonomie der pflanzen. Vol. V, 1969; 264-93, 444-9.
7. 7. Lavenir R, Paris RR. Sur les alcaloïdes de la Chélidoine (Chelidonium majus L.). Repartition dans divers organes, isolement de la stylopine à partir des fruits. Annales Pharm Françaises 1965; 23: 307-12.
8. 8. Fulde G, Wichtl M. Bilder aus Pharmazie und Medizin. Deutsche Apotheker Zeitung 1993; 133: 1807-10.
9. 9. Zenk MH. Plant Nitrogen Metabolism. In: Recent advances in phytochemistry. 1988; 23: 429-57.
10. 10. Roth L, Daunderer M, Kormann K. Giftpflanzen-Pfanzengifte: Vorkommen-Wirkung-Therapie. 1984; 1, 4, 6, 7, 14, 26, 27.
11. 11. Slavík J, Slavíková L. Minor alkaloids from Chelidonum majus L. Collection Czechoslov Chem Commun 1977; 42: 2686-93.
12. 12. Niu C, He L. Review of the studies on Chelidonium majus L. Zhongguo Yaoxue Zazhi 1994; 29: 138-140 (C.A. 120: 279936z).
13. 13. De Rosa S, Di Vincenzo G. Isochelidonine, a benzophenanthridine alkaloid from Chelidonium majus. Phytochemistry 1992; 31: 1085-6.
14. 14. Kadan G, Gözler T, Shamma M. Turkiyenine, a new alkaloid from Chelidonium majus. J Nat Products 1990; 53: 531-2.
15. 15. Kadan G, Gözler T, Hesse M. Norchelidonine from Chelidonium majus. Planta Med 1992; 58: 477.
16. 16. Tamas M, Chindris E, Roman L, Tuia M. Alkaloids of Chelidonium majus L. Clujul Med 1987 60: 256-60.
17. 17. Tomè F, Colombo ML. Alkaloids from Chelidonium majus: distribution in the plant and factors affecting their accumulation. Phytochemistry 1995; 40: 3-39.
18. 18. Preininger V. Chemotaxonomy of Papaveraceae and Fumariaceae. In: The Alkaloids 1986; Vol. 29: Chapter I.
19. 19. Hahn R, Nahrstedt A. Hydroxycinnamic acid derivatives, caffeoylmalic and new caffeoylaldonic acid esters, from Chelidonium majus. Planta Med. 1993; 59: 71-5.
20. 20. Lozyuk LV. Antiviral properties of some compounds of plant origin. Mikrobiol. Zh (Kiev) 1977; 39: 343-8.
21. 21. Furusawa E, Furusawa S, Kroposki M, Cutting W. Higher plants as a source of antiviral agents. Prog Antimicrob Anticancer Chemother 1970; 2: 810-17.
22. 22. Horvath J, Kery A, Kulcsar G, Dan P, Nasz J. Antiviral effect of Chelidonium extracts. Proc Int Congr Chemother 13th 1983; 9: 124/106-124/110.
23. 23. Amoros M, Fauconnier B, Girre L. Propriétés antivirales de quelques extraits de plantes indigènes. Annales Pharm Françaises 1977; 35: 371-6.
24. 24. Sethi ML. Screening of benzophenanthridine alkaloids for their inhibition of reverse transcriptase activity and preliminary report on the structure-activity relationships. Can J Pharm Sci 1981; 16: 29-34.
25. 25. Sethi ML. Enzyme Inhibition VI: Inhibition of Reverse Transcriptase Activity by Protoberberine Alkaloids and Structure-Activity Relationships. J Pharm Sci 1983; 72: 538-41.
26. 26. Sethi ML. Comparison of inhibition of reverse transcriptase and antileukemic activities exhibited by protoberberine and benzophenanthridine alkaloids and structure-activity relationships. Phytochemistry 1985; 24: 447-54.
27. 27. Kery A, Horvath J, Nasz I, Verzar-Petri G, Kulcsar G, Dan P. Antiviral alkaloids in Chelidonium majus L. Acta Pharm Hung 1987; 57: 19-25 (CA 107: 4134x).
28. 28. Tan GT, Pezzuto J, Kinghorn AD. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J Nat Prod 1991; 54: 143-54.
29. 29. Sokoloff B. The oncostatic and oncolytic factors present in certain plants. Oncology 1968; 22: 49-60.
30. 30. Hladon B, Kowalewski Z, Bobkiewicz T, Gronostaj K. Cytotoxic activity of some Chelidonium majus alkaloids on human and animal tumor cell cultures in vitro. Ann Pharm (Poznan) 1978; 13: 61-8.
31. 31. Caolo MA, Stermitz FR. Benzophenanthridinium salt equilibria. Heterocycles 1979; 12: 11-15.
32. 32. Cohen HG, Seifen EE, Straub KD, Tiefenback C, Stermitz FR. Structural specificity of the NaK-ATPase inhibition by sanguinarine, an isoquinoline benzophenanthridine alkaloid. Biochem Pharmacol 1978; 27: 2555-8.
33. 33. Ishii H, Ichikawa Y, Kawanabe E, Ishikawa M, Ishikawa T, Kuretani K, Inomata M, Hoshi A. Studies on the chemical constituents of rutaceous plants. LX. Development of a versatile method for syntheses of the antitumoral benzo[c]phenanthridine alkaloids. Efficient syntheses and antitumoral activities of nitidine and related nonphenolic benzo[c]phenathridine alkaloids. Chem Pharm Bull 1985; 33: 4139-51.
34. 34. Stermitz FR, Gillespie JP, Amoros LG, Romero R, Stermitz TA, Larson KA, Earl S, Ogg JE. Synthesis and biological activity of some antitumoral benxophenanthridinium salts. J Med Chem 1975; 18: 708-13.
35. 35. Perez D, Guitain E, Castedo L. A new approach to the systhesis of antitumor benzophenanthridine alkaloids. J Org Chem 1992; 57: 5911-17.
36. 36. Zbierska J, Kowalewski Z. Anticancer and antibiotic properties of N-methylchelidonine methyl sulfate. Herba Pol 1979; 25: 311-16.
37. 37. Zbierska J, Kowalewski Z. Antineoplastic and antibiotic properties of chelidonine N-oxide. Herba Pol 1980; 26: 61-6.
38. 38. Turkevich NM, Olievskaya MS, Pashkevich YM, Potopal'skii AI, Novitskii VM. Compounds of thiophosphoramide with Chelidonium majus alkaoloids. U.S.S.R. 368254, 1973.
39. 39. Nowicky W. Diagnostic and therapeutic treatment of tumors and/or infectious diseases of all types using alkaloids compositions or their salts. PCT Int. Appl. WO 83 00 486, 1983.
40. 40. Nowicky J, Greif M, Hamler F, Hismayr W, Staub W. Biological Activity of ukrain in vitro and in vivo. Chemioterapia 1987; 6: 683-5.
41. 41. Petlichnaya LI, Oleevskaya MS, Maslova LI, Potopal'skii AI. Interaction of thiophosphamide and alkaloids from greater celandine. Farm Zh (Kiev) 1982; (6)68-69.
42. 42. Nowicky W. Treatment of AIDS with Thiophosphate Derivative of Chelidoium Majus Alkaloids. U.S. US 4970212, 1990.
43. 43. Nowicky JW, Staniszewski A, Zbroja-Sontag W, Slesak B, Nowicky W, Hiesmayr W. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas. Drugs Exp Clin Res 1991; 17: 139-43.
44. 44. Liepins A, Nowicky JW. Activation of spleen cell lytic by the alkaloid thiophosphoric acid derivative: Ukrain. Int J Immunopharmac 1992; 14: 1437-42.
45. 45. Maiti M, Nandi R, Chaudhuri K. Sanguinarine : a monofunctional intercalating alkaloid. FEBS Lett 1982; 142: 280-4.
46. 46. Smekal E, Kubova N, Kleinwachter V. Interaction of benzophenanthridine alkaloid sanguinarine with DNA. Stud Biophys 1984; 101: 125-32.
47. 47. Faddejeva M, Belyaeva TN. Rosanov YuM., Sedova VM., Sokolovskaya EL. Studies on the complex formation with DNA and the effect on DNA hydrolysis, RNA synthesis and cellular membrane ATPase systems of some antitumor agents including alkaloids. Stud Biophys 1984; 104: 267-9.
48. 48. Smekal E, Kubova N, Kleinwachter V. DNA-chelerythrine interaction and binding isotherms. Stud Biophys 1985; 105: 77-84.
49. 49. Krey AK, Hahn FE. Berberine: Complex with DNA. Science 1969; 166: 755-7.
50. 50. Smekal E, Kubova N. Alkaloids of protoberberine and benzophenathridine groups as intercalating drugs with DNA. Stud Biophys 1984; 101: 121-3.
51. 51. Mitscher LA, Park YH, Clark D, Clark GW, Hammesfahr PD, Wu WN, Beal JL. Antimicrobial agents from higher plants. An investigation of Hunnemannia fumariaefolia pseudoalcoholates of sanguinarine and chelerythrine. Lloydia (J Nat Prod) 1978; 41: 145-9.
52. 52. Zhu B, Ahrens FA. Effect of berberine on intestinal secretion mediated by Escherichia coli heat-stable enterotoxin in jejunum of pigs. Am J Vet Res 1982; 43: 1594-8.
53. 53. Pitea M, Margineanu C. Correlations between chemical structure and antibacterial activity of berberine. Clujul Med. 1972; 45: 465-9.
54. 54. Southard G. Lee Benophenanthridine alkaloids-containing solutions for treating periodontal diseases. U.S. US 4683133, 1987.
55. 55. Boulware RT, Southard GL, Yankell SL. Sanguinaria extract, a new agent for the control of volatile sulfur compounds in the oral cavity. J Soc Cosmet Chem 1985; 36: 297-302.
56. 56. Tsurui Yakuhin Kogyo KK. Anticaries agents. Jpn. Kokai Tokkyo JP 82 85319, 1982.
57. 57. Hbjtmankova N, Walterova D, Preininger V. Antifungal activity of quaternary benzo[c]phenanthridine alkaloids from Chelidonium majus. Planta Med 1981; 43: 161-5.
58. 58. Lenfeld J, Kroutil M, Marsalek E, Slavick J, Preininger V, Simanek V. Antiinflammatory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus. Planta Med 1981; 43: 161-5.
59. 59. Vukusic I, Pepljnjak S, Kustrak D, Grungold D. Investigation of the antimycotic activities of Chelidonium majus extract. Planta Med 1991; 57 (suppl. 2): A 46.
60. 60. Mahajan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulfate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982; 20: 79-81.
61. 61. Kleinrok Z, Jagiello-Wojtowicz E, Matuszek B, Chodkowska A. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. Pol J Pharmacol Pharm 1992; 44: 227-39
62. 1) Receptors. Plant Med 1992; 58: 35-8.
63. 63. Vahensieck U, Hahn R, Winterhoff H, Gumbinger HG, Nahrsted A, Kemper FH. The effect of Chelidonium majus herb extract on choleresis in the isolated perfused rat liver. Planta Med 1995; 61: 267-70.